Oct. 29 at 3:21 PM
$MTLS Manufacturing and software are still contracting and Medical growth is slowing. This is a very low growth company overall with serious competition. They will likely be acquired one day for the medical aspect because low volume personalization is a great strength in additive. Manufacturing with additive is still constrained because of costs, slow processes compared to traditional and competition. The use cases are still meager.